(Q35892694)

English

Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS).

scientific article published in April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS). (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

0 references

author name string

J Bernard Walsh

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Willem F Lems

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Dimitrios Karras

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Bente L Langdahl

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Osten Ljunggren

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Astrid Fahrleitner-Pammer

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Annabel Barrett

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Gerald Rajzbaum

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Franz Jakob

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Fernando Marin

10

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 April 2012

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Calcified Tissue International

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

90

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

373-383

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

Meta-analysis: excess mortality after hip fracture among older women and men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

From randomized controlled trials to observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

Osteoporosis: an age-related and gender-specific disease--a mini-review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

Back pain in osteoporotic vertebral fractures.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

Quality of life in patients with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

Pathogenesis of bone fragility in women and men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

EQ-5D: a measure of health status from the EuroQol Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

Vitamin D3 and calcium to prevent hip fractures in elderly women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327838

11 July 2018

Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9590-9

21 January 2018

Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9590-9

21 January 2018

Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY study

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9590-9

21 January 2018

Risk factors for vertebral and nonvertebral fracture over 10 years: a population-based study in women

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9590-9

21 January 2018

The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA).

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9590-9

21 January 2018

Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old.

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9590-9

21 January 2018

Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9590-9

21 January 2018

Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective.

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9590-9

21 January 2018

Clinical consequences of vertebral fractures

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9590-9

21 January 2018

Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9590-9

21 January 2018

Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9590-9

21 January 2018

Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22466444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/22466444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00223-012-9590-9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35892694&oldid=2197928965"